SCHEMBL2202067

SCHEMBL2202067

Cc1cnc(CNC(=O)c2ccc3cccnc3c2O)cn1

nearest known ligand 0.63

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 17/20 0.63
ALDH1A1 P00352 2/20 0.51
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199705 0.82 EGLN1 (0.61) EGLN1ALDH1A1
SCHEMBL2203862 0.82 EGLN1 (0.74) EGLN1ALDH1A1HPGDHTT
SCHEMBL2201303 0.81 EGLN1 (0.62) EGLN1ALDH1A1
SCHEMBL15327101 0.80 SMN1; SMN2 (0.41) EGLN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL7691436 0.79 EGLN1 (0.70) EGLN1ALDH1A1HPGDHTT
SCHEMBL2200760 0.78 EGLN1 (1.00) EGLN1ALDH1A1
SCHEMBL2202181 0.77 EGLN1 (0.79) EGLN1ALDH1A1HPGDHTT
SCHEMBL7685030 0.77 EGLN1 (0.74) EGLN1ALDH1A1HPGD
SCHEMBL2204239 0.77 EGLN1 (0.83) EGLN1ALDH1A1HTT
SCHEMBL2202703 0.76 EGLN1 (0.66) EGLN1ALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US claimed
US-8729076-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA (LU) 2014-05-20 US claimed
CN-102712596-B Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA 2014-04-09 CN claimed
EP-2519504-B1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. POLICHEM SA (LU) 2014-03-19 EP claimed
EP-2519503-B1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2013-10-23 EP claimed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US claimed
US-20120316167-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES POLICHEM SA (LU) 2012-12-13 US claimed
EP-2519503-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2012-11-07 EP claimed
CN-102712596-A novel secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA 2012-10-03 CN claimed
CN-102712597-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives as antifungal agents POLICHEM SA 2012-10-03 CN claimed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP claimed
EP-2345641-A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM S.A. (LU) 2011-07-20 EP claimed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO claimed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
CN-102712597-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives as antifungal agents POLICHEM SA 2012-10-03 CN disclosed
CN-102712596-A novel secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA 2012-10-03 CN disclosed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP disclosed
EP-2345641-A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM S.A. (LU) 2011-07-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS ERG28, TUBA8, CYP51A1 EGLN1 1246/4885ALDH1A1 1232/4885HPGD 2472/4885
US-20120316167-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES TUBA8, CYP51A1, ERG28 EGLN1 946/4885ALDH1A1 1383/4885HPGD 2788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.